Roche snaps up Bielefeld spin-out Innovatis for €15M

Acquisition

Innovatis AG, a provider of automated cell analysis solutions, especially focusing on cell counting, viability testing, and call function analysis is to be acquired by the diagnostics arm of Roche, in a €15 million cash deal.

Innovatis, spun-out from Bielefeld University, Germany, in 2002, will become part of Roche Applied Science, and will continue to develop and market products for cell analysis through Roche Applied Sciences’ worldwide network.

“This acquisition is a further step in our strategy to strengthen our position as a complete solution provider in the cell analysis research market,” said Jürgen Schwiezer, CEO Division Roche Diagnostics. “Innovatis’ technology will complement the existing Roche cell analysis portfolio.”